Olatuton 20 mg powder and solvent for prolonged-release suspension for injection

Licence status
Authorised: 19/08/2019
Active substances
Octreotide
Dosage Form
Powder and solvent for prolonged-release suspension for injection
Licence number
PA1986/076/002
Licence holder
Teva B.V.

Product documents

Licence information

ATC code
H01CB Somatostatin and analogues, H01CB02 octreotide
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
19/08/2019

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie